Compare ATRC & OLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | OLN |
|---|---|---|
| Founded | 2000 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | 2005 | 1994 |
| Metric | ATRC | OLN |
|---|---|---|
| Price | $55.75 | $15.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 16 |
| Target Price | ★ $55.78 | $19.81 |
| AVG Volume (30 Days) | 914.1K | ★ 3.9M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $201,630,000.00 | ★ $6,780,800,000.00 |
| Revenue This Year | $13.42 | $2.17 |
| Revenue Next Year | $12.12 | $4.87 |
| P/E Ratio | $311.17 | ★ N/A |
| Revenue Growth | ★ 15.40 | 3.68 |
| 52 Week Low | $25.36 | $14.64 |
| 52 Week High | $61.70 | $30.46 |
| Indicator | ATRC | OLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.56 | 37.96 |
| Support Level | $26.95 | $14.95 |
| Resistance Level | $61.70 | $16.65 |
| Average True Range (ATR) | 2.28 | 0.59 |
| MACD | -0.32 | 0.05 |
| Stochastic Oscillator | 56.81 | 25.19 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Olin was founded in 1892 and has been publicly listed since 1917. The company has a unique dual identity compared with some of its chemical peers: it is the world's largest chlor-alkali producer by capacity, and it owns the Winchester brand, a leading US ammunition manufacturer. Olin has three reportable segments: chlor-alkali products and vinyls (CAPV or CAP), Epoxies, and Winchester, which represent around 55%, 20%, and 25% of sales, respectively.